» Articles » PMID: 16807539

Vascular Defect Beyond the Endothelium in Type II Diabetic Patients with Overt Nephropathy and Moderate Renal Insufficiency

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2006 Jun 30
PMID 16807539
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

There is a paucity of data on the effects of overt nephropathy and moderate renal impairment on endothelial function in diabetic patients. A total of 26 type II diabetic (DM) patients with nephropathy (DMN+) (mean +/- s.d. age: 63.7 +/- 6.3 years), 32 diabetic patients without nephropathy (DMN-) (59.4 +/- 10.1 years), and 52 non-diabetic subjects (54.9 +/- 8.2 years) were recruited. High-resolution ultrasound scan was used to measure carotid intima media thickness (IMT) and flow-mediated dilation (FMD) of the brachial artery. Endothelium-independent dilation was determined by maximal vascular dilation after sublingual nitroglycerine (glyceryl trinitrate (GTN)-induced dilation). The mean carotid IMT increased progressively from non-DM to DMN- to DMN+ groups (0.74 +/- 0.23 vs 0.80 +/- 0.25 vs 1.03 +/- 0.38 mm; P=0.001 for trend) whereas FMD- (4.3 +/- 2.5 vs 3.9 +/- 1.7 vs 1.9 +/- 2.0%, P<0.001 for trend) and GTN-induced dilation (14.7 +/- 4.0 vs 14.5 +/- 3.9 vs 10.3 +/- 3.2%; P<0.001 for trend) declined in an opposite manner. On multivariate analysis, age (beta=0.257, P=0.009), glomerular filtration rate (beta=-0.364, P<0.001), and smoking (beta=0.25, P=0.013) were independently associated with carotid IMT (F=15.76, R(2)=0.340, P<0.001). After adjustment for baseline brachial arterial diameter, history of smoking (beta=-0.039, P<0.001), fasting plasma glucose (beta=-0.033, P=0.002), and total cholesterol (beta=-0.023, P=0.024) were independently associated with vessel diameter after FMD (F=2446.5, R(2)=0.992, P<0.001); whereas age (beta=-0.069, P=0.001) and urinary albumin excretion (beta=-0.048, P=0.018) were independently associated with vessel diameter after GTN (F=851.6, R(2)=0.967, P<0.001). Type II diabetic patients with overt nephropathy and moderate renal impairment had both structural and functional vascular abnormalities beyond the endothelium.

Citing Articles

Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.

Di Marco M, Scilletta S, Miano N, Marrano N, Natalicchio A, Giorgino F Cardiovasc Diabetol. 2023; 22(1):344.

PMID: 38093293 PMC: 10720121. DOI: 10.1186/s12933-023-02065-2.


Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population.

Kourtidou C, Rafailidis V, Varouktsi G, Kanakis E, Liakopoulos V, Vyzantiadis T J Pers Med. 2022; 12(7).

PMID: 35887636 PMC: 9319005. DOI: 10.3390/jpm12071139.


Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease.

Ito H, Nakashima M, Meguro K, Furukawa H, Yamashita H, Takaki A J Diabetes Res. 2015; 2015:728127.

PMID: 26064988 PMC: 4429217. DOI: 10.1155/2015/728127.


eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.

Kosugi T, Heinig M, Nakayama T, Matsuo S, Nakagawa T Am J Pathol. 2010; 176(2):619-29.

PMID: 20042665 PMC: 2808070. DOI: 10.2353/ajpath.2010.090578.


Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

Li J, Qu X, Bertram J Am J Pathol. 2009; 175(4):1380-8.

PMID: 19729486 PMC: 2751535. DOI: 10.2353/ajpath.2009.090096.